Photo from Katsuaki Maehara/X
Oct 11, 2024, 15:17
Katsuaki Maehara: Summary of Major Clinical Trials of ICI’s in Early Stage NSCLC
Katsuaki Maehara, Director of Medical Education Colleagues, shared a post on X:
”Summary of Major Clinical Trials of Immune Checkpoint Inhibitors (ICI’s) in Early Stage NSCLC. As of September 2024.
Study design.
Key Clinical Data.”
Source: Katsuaki Maehara/X
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Oct 11, 2024, 15:17
Oct 11, 2024, 15:08
Oct 11, 2024, 15:01
Oct 11, 2024, 14:59
Oct 11, 2024, 14:52
Oct 11, 2024, 14:37